112 related articles for article (PubMed ID: 36800710)
1. Is complete pathological response truly a complete response in breast cancer?
Rehman B; Rehman S; Mohtasham S; Zahid T; Sarwar A; Parvaiz MA
J Pak Med Assoc; 2023 Feb; 73(2):280-283. PubMed ID: 36800710
[TBL] [Abstract][Full Text] [Related]
2. Breast conservation surgery (BCS) for breast cancer in a resource limited country - Are we upto the challenge!
Javed N; Rehman B; Iqbal E; Afzal S; Jamal A; Parvaiz MA
J Pak Med Assoc; 2021 Dec; 71(12):2748-2754. PubMed ID: 35150532
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.
Aebi S; Gelber S; Anderson SJ; Láng I; Robidoux A; Martín M; Nortier JW; Paterson AH; Rimawi MF; Cañada JM; Thürlimann B; Murray E; Mamounas EP; Geyer CE; Price KN; Coates AS; Gelber RD; Rastogi P; Wolmark N; Wapnir IL;
Lancet Oncol; 2014 Feb; 15(2):156-63. PubMed ID: 24439313
[TBL] [Abstract][Full Text] [Related]
5. Risk factors effecting development of metachronous liver metastasis in rectal cancer patients after curative surgical resection. Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore experience.
Khan MS; Bakar MA; Saba A; Khan MA; Akbar SA; Islam Nasir IU
J Pak Med Assoc; 2019 Feb; 69(2):201-204. PubMed ID: 30804584
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Systemic Therapy.
Farrukh N; Bano R; Naqvi SRQ; Latif H
J Coll Physicians Surg Pak; 2022 Jun; 32(6):746-750. PubMed ID: 35686406
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of the AJCC 8th edition staging system for selecting patients with T1-2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions.
Wang S; Wen G; Tang Y; Yang Y; Jing H; Wang J; Zhang J; Zhao X; Sun G; Jin J; Song Y; Liu Y; Fang H; Zhang Y; Li Y
BMC Cancer; 2020 Aug; 20(1):792. PubMed ID: 32838753
[TBL] [Abstract][Full Text] [Related]
8. Post-mastectomy radiation beyond chest wall in patients with N1 breast cancer: is there a benefit?
Yadav BS; Sharma SC; George P; Bansal A
J Cancer Res Ther; 2014; 10(2):279-83. PubMed ID: 25022378
[TBL] [Abstract][Full Text] [Related]
9. Pathologic Complete Response in HER2-Positive Breast Cancer Patients Receiving Trastuzumab in Neoadjuvant Setting.
Sheikh F; Nazir A; Yasmeen S; Badar F; Ahmad U; Siddiqui N
J Coll Physicians Surg Pak; 2019 Feb; 29(2):159-163. PubMed ID: 30700356
[TBL] [Abstract][Full Text] [Related]
10. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].
Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235
[No Abstract] [Full Text] [Related]
11. Retrospective study of ovarian malignancy managed in surgical unit at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore.
Ali SI; Sayyed RH; Akbar SA; Abubakar M; Syed AA
J Pak Med Assoc; 2021 Feb; 71(2(B)):696-698. PubMed ID: 33941961
[TBL] [Abstract][Full Text] [Related]
12. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
Alabdulkareem H; Pinchinat T; Khan S; Landers A; Christos P; Simmons R; Moo TA
Breast J; 2018 Mar; 24(2):148-153. PubMed ID: 28707744
[TBL] [Abstract][Full Text] [Related]
13. Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.
Chuwa EW; Tan VH; Tan PH; Yong WS; Ho GH; Wong CY
ANZ J Surg; 2008; 78(1-2):42-8. PubMed ID: 18199204
[TBL] [Abstract][Full Text] [Related]
14. Local-regional breast cancer recurrence: prognostic groups based on patterns of failure.
Moran MS; Haffty BG
Breast J; 2002; 8(2):81-7. PubMed ID: 11896752
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of primary non-metastatic breast cancer: A single institution experience.
Jamshed A; Shah MA; Syed AA; Murtaza G; Mehmood T; Chaudry SJ; Loya A; Hameed S
Indian J Cancer; 2015; 52(1):119-25. PubMed ID: 26837998
[TBL] [Abstract][Full Text] [Related]
16. Early response to neo-adjuvant chemotherapy in carcinoma of the breast predicts both successful breast-conserving surgery and decreased risk of ipsilateral breast tumor recurrence.
Ishitobi M; Komoike Y; Motomura K; Koyama H; Inaji H
Breast J; 2010; 16(1):9-13. PubMed ID: 19929889
[TBL] [Abstract][Full Text] [Related]
17. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.
Resende U; Cabello C; Ramalho SOB; Zeferino LC
BMC Cancer; 2019 Jun; 19(1):601. PubMed ID: 31208353
[TBL] [Abstract][Full Text] [Related]
18. Response and Prognosis of Docetaxel and Cyclophosphamide as Neoadjuvant Chemotherapy in ER
Hayashi N; Yagata H; Tsugawa K; Kajiura Y; Yoshida A; Takei J; Yamauchi H; Nakamura S
Clin Breast Cancer; 2020 Dec; 20(6):462-468. PubMed ID: 33046356
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Venkatesan V; Dar AR; Stitt L
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):541-50. PubMed ID: 9231678
[TBL] [Abstract][Full Text] [Related]
20. Predictors of time to death after distant recurrence in breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
